ADAC secures Japanese clearances

Article

Regulatory clearances obtained in late September will enable Sumitomo Metal Industries, the exclusive sales agent for ADACLaboratories in Japan, to begin selling several dual-head gammacameras designated for export to Japan by the Milpitas, CA, company.

Regulatory clearances obtained in late September will enable Sumitomo Metal Industries, the exclusive sales agent for ADACLaboratories in Japan, to begin selling several dual-head gammacameras designated for export to Japan by the Milpitas, CA, company.

The Japanese Ministry of Health and Welfare approved applicationsfor ADAC's Vertex Plus, Solus, and Cardio nuclear imaging systems.The ministry also cleared Molecular Coincidence Detection, ADAC'shigh-energy imaging technique.

Vertex Plus is ADAC's premium variable-angle camera, Solusis a fixed 180° dual-head optimized for oncology, and Cardiois a fixed 90° dual-head system devoted to cardiology.

The approval of MCD was the first of its kind for a high-energyimaging system in Japan, according to ADAC officials. ADAC's optionalMCD feature enables Vertex and Solus gamma cameras to performcoincidence-based fluorodeoxyglucose (FDG) imaging with a SPECTcamera.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.